客服熱線:703 - 9861
非企業(yè)會(huì)員
英文名稱 | 中文名稱 | CAS號(hào) | 操作 |
PFM01 | PFM01 | 1558598-41-6 | 詳細(xì) |
PH 797804, (±)- - rac-PH 797804 | rac-PH 797804 | PH-797804 | 586379-66-0 | 詳細(xì) |
PHA 408 | PHA 408 | 503555-55-3 | 詳細(xì) |
PHA-767491 | PHA767491 | 845714-00-3 | 詳細(xì) |
PHT 427 | 4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 | 1191951-57-1 | 詳細(xì) |
PI 103 hydrochloride | PI-103 (Hydrochloride) | 371935-79-4 | 詳細(xì) |
PIK 75 hydrochloride | 2-甲基-5-硝基苯磺酸 (2E)-2-[(6-溴咪唑并[1,2-A]吡啶-3-基)亞甲基]-1-甲酰肼 | 945619-31-8 | 詳細(xì) |
PIK 90 | N-(2,3-二氫-7,8-二甲氧基咪唑并[1,2-C]喹唑啉-5-基)-3-吡啶甲酰胺 | 677338-12-4 | 詳細(xì) |
Piperlongumine - Piplartine | 蓽茇酰胺 | 20069-09-4 | 詳細(xì) |
PKG drug G1 | 374703-78-3 | 374703-78-3 | 詳細(xì) |
PKI 587 - PF 05212384 | N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-嗎啉基)-1,3,5-三嗪-2-基]苯基]脲 | 1197160-78-3 | 詳細(xì) |
PluriSIn #1 - NSC 14613 | Pluripotent cell-specific inhibitor #1 | NSC 14613 | 91396-88-2 | 詳細(xì) |
PLX 4032 - RG 7204 | Vemurafenib | RO 5185426 | 維羅非尼 | 918504-65-1 | 詳細(xì) |
PLX 4720 | N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺 | 918505-84-7 | 詳細(xì) |
PND 1186 - SR 2516 | VS 4718 | PND1186 | 1061353-68-1 | 詳細(xì) |
PNU 100480 - PF 02341272 | U 100480 | Sutezolid | PF-02341272 | 168828-58-8 | 詳細(xì) |
Posaconazole - SCH 56592 | Noxafil | 泊沙康唑 | 171228-49-2 | 詳細(xì) |
PPP hydrochloride | 21602-56-2 | 詳細(xì) | |
Pravadoline - WIN 48098 | 普拉朵林 | 92623-83-1 | 詳細(xì) |
PRMT3 inhibitor 1 - Compound 1 | 1340875-03-7 | 詳細(xì) | |
PRT 4165 - NSC 600157 | PRT4165 | 31083-55-3 | 詳細(xì) |
PS 1145 | PS-1145 | 431898-65-6 | 詳細(xì) |
PS 47 | PS47;PS 47 | 1180676-33-8 | 詳細(xì) |
PS 48 | (Z)-5-(4-氯苯基)-3-苯基戊-2-烯酸 | 1180676-32-7 | 詳細(xì) |
PTIQ | PTIQ | 1032822-42-6 | 詳細(xì) |
PU-H71 trihydrochloride | 2108826-10-2 | 詳細(xì) | |
PXS 4728A - PXS 4728 HCl | PXS 4728A | 1478364-68-9 | 詳細(xì) |
Pyroxamide | N-羥基-N'-3-吡啶基辛二酰胺 | 382180-17-8 | 詳細(xì) |
R 406 | R-406 | 841290-80-0 | 詳細(xì) |
R 547 | [4-氨基-2-[(1-甲磺?;哙?4-基)氨基]嘧啶-5-基](2,3-二氟-6-甲氧基苯基)甲酮 | 741713-40-6 | 詳細(xì) |
RAD51 inhibitor B02 | RAD51 INHIBITOR B02 | 1290541-46-6 | 詳細(xì) |
RAF709 | 化合物RAF709 | 1628838-42-5 | 詳細(xì) |
Rapamycin - Sirolimus | 雷帕霉素 | 53123-88-9 | 詳細(xì) |
RBC 8 | RBC8 | 361185-42-4 | 詳細(xì) |
Rbin-1 - Ribozinoindole-1 | RBIN-1 | 328023-11-6 | 詳細(xì) |
Rbin-2 - Ribozinoindole-2 | Rbin-2 - Ribozinoindole-2 | 2032282-97-4 | 詳細(xì) |
Regorafenib - BAY 73-4506 | Stivarga | 瑞格非尼 | 755037-03-7 | 詳細(xì) |
Remodelin | REMODELIN | 949912-58-7 | 詳細(xì) |
REP 3123 dihydrochloride - CRS3123 dihydrochloride | REP 3123 DIHYDROCHLORIDE | 1013915-99-5 | 詳細(xì) |
REP 8839 | 貝得羅星 | 757942-43-1 | 詳細(xì) |
Reversine | REVERSINE | 656820-32-5 | 詳細(xì) |
RG 108 | RG108 | 48208-26-0 | 詳細(xì) |
RGFP 966 | RGFP966 | 1357389-11-7 | 詳細(xì) |
RI-1 | 3-氯-1-(3,4-二氯苯基)-4-(4-嗎啉基)-1H-吡咯-2,5-二酮 | 415713-60-9 | 詳細(xì) |
Rigosertib sodium - ON01910 sodium | Estybon | 瑞格色替鈉 | 592542-60-4 | 詳細(xì) |
RIPA-56 | RIPA-56 | 1956370-21-0 | 詳細(xì) |
RITA - NSC 652287 | 5,5'-(2,5-呋喃二基)二-2-噻吩甲醇 | 213261-59-7 | 詳細(xì) |
RKI 1447 | 1-(3-羥基芐基)-3-(4-(吡啶-4-基)噻唑-2-基)脲 | 1342278-01-6 | 詳細(xì) |
RO 28-0450 - RO 28-1675, (±)- | 3-CYCLOPENTYL-2-(4-METHANESULFONYL-PHENYL)-N-THIAZOL-2-YL-PROPIONAMIDE | 300352-96-9 | 詳細(xì) |
RO 28-1674 - RO 28-0450, (S)- | 599164-57-5 | 詳細(xì) | |
RO 28-1675 - RO 28-0450, (R)- | (2R)-3-環(huán)戊基-2-[4-(甲基磺?;?苯基]-N-(噻唑-2-基)丙酰胺 | 300353-13-3 | 詳細(xì) |
RO 3306 | 2-[[(噻吩-2-基)甲基]氨基]-5-[1-(喹啉-6-基)甲-(Z)-亞基]噻唑-4-酮 | 872573-93-8 | 詳細(xì) |
RO 4929097 | N1-[(7S)-6,7-二氫-6-氧代-5H-二苯并[B,D]氮雜卓-7-基]-2,2-二甲基-N3-(2,2,3,3,3-五氟丙基)丙二酰胺 | 847925-91-1 | 詳細(xì) |
RO 61-8048 | RO 61-8048 | 199666-03-0 | 詳細(xì) |
Roflumilast - Daxas | BY 217 | BYK 20869 | B 9302-107 | 羅氟司特 | 162401-32-3 | 詳細(xì) |
PF 06260933 dihydrochloride | PF 06260933 dihydrochloride | 1883548-86-4 | 詳細(xì) |
PF 06447475 | PF-06447475 | 1527473-33-1 | 詳細(xì) |
PF 06463922 - Lorlatinib | 勞拉替尼 | 1454846-35-5 | 詳細(xì) |
PF 06465469 | PF 06465469 Discontinued See A191400 | 1407966-77-1 | 詳細(xì) |
PF 3845 | PF 3845 | 1196109-52-0 | 詳細(xì) |
PF 431396 | N-甲基-N-[2-[[[2-[(2-氧代-2,3-二氫-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]苯基]甲磺酰胺 | 717906-29-1 | 詳細(xì) |
PF 4693627 - PF 04693627 | PF-4693627 | 1312815-93-2 | 詳細(xì) |
PF 4708671 - PF 04708671 | PF-4708671 | 1255517-76-0 | 詳細(xì) |
PF 477736 - PF 00477736 | PF 477736 | 952021-60-2 | 詳細(xì) |
PF 4800567 | PF 4800567 | 1188296-52-7 | 詳細(xì) |
PF 543 citrate | (2R)-1-[[4-[[3-甲基-5-[(苯磺?;?甲基]苯氧基]甲基]苯基]甲基]-2-吡咯烷甲醇檸檬酸鹽 | 1415562-83-2 | 詳細(xì) |
PF 573228 | 6-[(4-((3-(甲磺?;?芐基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氫-1H-喹啉-2-酮 | 869288-64-2 | 詳細(xì) |
PF 956980 | PF-956980 | 1262832-74-5 | 詳細(xì) |
PFK 158 | PFKFB3抑制劑(PFK-158) | 1462249-75-7 | 詳細(xì) |
Rolipram | 諾普利蘭 | 61413-54-5 | 詳細(xì) |
Rolipram, (R)-(-)- | (4R)-4-[3-(環(huán)戊氧基)-4-甲氧基苯基]吡咯-2-酮 | 85416-75-7 | 詳細(xì) |
Rolipram, (S)-(+)- | S- (+)-Rolipram | 85416-73-5 | 詳細(xì) |
RS-1 - RAD51-Stimulatory Compound-1 | 4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺?;鵠苯甲酰胺 | 312756-74-4 | 詳細(xì) |
PF 00356231 | 化合物PF 00356231 | 766536-21-4 | 詳細(xì) |
PF 03814735 | N-[2-[(1S,4R)-6-[[4-(環(huán)丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氫萘-1,4-亞氨-9-基]-2-氧代乙基]乙酰胺 | 942487-16-3 | 詳細(xì) |
SB 747651A - SB 747651 tetrahydrochloride | 詳細(xì) | ||
PF 02341066 - Crizotinib | PF 2341066 | 克唑替尼 | 877399-52-5 | 詳細(xì) |
PF 04981517 - CYP3cide | PF 4981517 | PF-4981517 | 1390637-82-7 | 詳細(xì) |
PDK1 inhibitor 2610 | 2108463-93-8 | 詳細(xì) | |
SB 203580 | 4-(4-氟苯基)-2-(4-甲基亞磺?;交?-5-(4-吡啶基)-1H-咪唑 | 152121-47-6 | 詳細(xì) |
Perifosine - KRX 0401 | D 21266 | 哌立福辛 | 157716-52-4 | 詳細(xì) |
PF 04691502 | 2-氨基-8-[反式-4-(2-羥基乙氧基)環(huán)己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 | 1013101-36-4 | 詳細(xì) |
SB 939 - Pracinostat | (2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羥基丙烯酰胺 | 929016-96-6 | 詳細(xì) |
SB 706504 - PCG | 化合物 T23327 | 911110-38-8 | 詳細(xì) |
SB 590885 | 5-[2-[4-[2-(二甲基氨基)乙氧基]苯基]-5-(4-吡啶基)-1H-咪唑-4-基]-2,3-二氫-1-茚酮肟 | 405554-55-4 | 詳細(xì) |
PF 04859989 hydrochloride - L-3-Amino-3,4-dihydro-1-hydroxycarbstyril hydrochloride | (S)-3-aMino-1-hydroxy-3,4-dihydroquinolin-2(1H)-one hydrochloride | 177943-33-8 | 詳細(xì) |
SAR405838 - MI-77301 | SAR 405838 | 1303607-60-4 | 詳細(xì) |
SAR405 | CS-2552 | 1523406-39-4 | 詳細(xì) |
S3QEL 2 | S3QEL 2 | 890888-12-7 | 詳細(xì) |
SB 207499 - Cilomilast | Ariflo | 西洛司特 | 153259-65-5 | 詳細(xì) |
SB 203580 hydrochloride | SB 203580鹽酸鹽 | 869185-85-3 | 詳細(xì) |
SB 202190 | 4-(4-氟苯基)-2-(4-羥基苯基)-5-(4-吡啶基)-1H-咪唑 | 152121-30-7 | 詳細(xì) |
RUSKI-201 dihydrochloride | 化合物 RUSKI-201 DIHYDROCHLORIDE | 詳細(xì) | |
Santacruzamate A - CAY 10683 | HDAC抑制劑 | 1477949-42-0 | 詳細(xì) |
Ruxolitinib - INCB 018424 phosphate | 魯索利替尼磷酸鹽 | 1092939-17-7 | 詳細(xì) |
PF 05081090 - PF 5081090 | PF5081090 | 1312473-63-4 | 詳細(xì) |
PF 04447943 - PF 4447943 | PF 4447943 | 1082744-20-4 | 詳細(xì) |
RU-SKI 43 hydrochloride | Hhat Inhibitor | 詳細(xì) | |
Salermide | CS-2458 | 1105698-15-4 | 詳細(xì) |
SB 216763 | SB216763 | 280744-09-4 | 詳細(xì) |
產(chǎn)品總數(shù):763 產(chǎn)品頁(yè)碼: | ||||
1 2 3 4 5 6 7 8 |
商家暫時(shí)不對(duì)外公布